Thailand is an interesting distribution channel for ASAlaser’s therapeutic solutions: after the success achieved by the seminar dedicated to MLS® and Hilterapia® in three important hospitals in Bangkok (Bangkok Hospital, Rama 9 Hospital, and Piyavej Hospital), ASAlaser staff has scheduled some targeted initiatives between May 6 and 8.
6/8 May: the MLS® Laser Therapy to TDA Congress
In collaboration with the local distributor Dental Siam, ASA, after taking part in the edition of December with MLS®, has also participated in the second meeting of the TDA Congress, the important event in dentistry. Goal: to give visibility to MLS® therapy as the effective solution in treating TMD disorders and craniofacial pain. The Mphi D trolley and Mphi D 5 devices as well as a video explaining the application of MLS® in dentistry, have been shown at the dealer's stand. The next occasion to spread MLS® among the experts will be in September at FDI Congress, one among the leading international events in the dental field.
6 May: a specifically training for MLS®
MLS® Laser Therapy, the protagonist of ASAlaser’s Thai mission. The team of the company has organized at Bumrungrad International Hospital in Bangkok a training on the therapy with a focus on its application procedures and protocols of treatment. The hospital’s staff, together with doctors and physiotherapists of other important local medical facilities that have the Mphi and M6 devices, at the end of the course, were quite interested to continue the training in order to improve their skills and optimize the results achievable with the Laser therapy.
8 May: MLS® through the University benches
Not only doctors and therapists but also teachers of Mahidol University - one of the first university in Thailand for Medicine, Biological Science and Law according to the QS World University Rankings in 2015, ed - have taken part in the seminar "MLS® Laser Therapy: new therapeutic solution" organized by ASAlaser in collaboration with the local dealer IMS. ASA’s staff, guest of the Department of Physical Therapy, has deepened with the 60 participants in the seminar, theory and practice of the therapy.
Report of the Mission
«The seminars held during this visit to hospitals in Bangkok and to one of the Thailand's leading universities - says Lucio Zaghetto, ASAlaser’s CEO - have met the different needs of the participants interested in exploring not only the theoretical basis of the therapy, but also in verifying its applicability. All the scientific researches presented by ASAlaser and supporting MLS® have been well appreciated». Doctors and physiotherapists who have taken part in the training also have highlighted the value of the tools used during the courses that have been able to facilitate the explanation. «3D images and video, the dedicated app on iTunes and Android platform, as well as the video-conference system useful for distance training - says Giacomo Granozio, ASAlaser’s Area Manager - are some of the plus indispensable to facilitate the correct understanding of our therapies. Even in Thailand, we have had the proof». The interest of the participants in the workshops, together with the positive feedback of professionals during the TDA Congress, confirm that the Thai market is a valuable potential audience for MLS® Laser Therapy and ASA’s devices.
L'accesso alla visualizzazione dei prodotti e al materiale informativo è riservato agli operatori del settore in ottemperanza alla legislazione vigente. ASA richiede di qualificarsi come operatore del settore per procedere con la navigazione.
Decreto Legislativo 24 febbraio 1997, n°46 Articolo 21
1. E' vietata la pubblicità verso il pubblico dei dispositivi che, secondo disposizioni adottate con decreto del Ministro della Sanità, possono essere venduti soltanto su prescrizione medica o essere impiegati eventualmente con l'assistenza di un medico o di altro professionista sanitario.
2. La pubblicità presso il pubblico dei dispositivi diversi da quelli di cui al comma 1 è soggetta ad autorizzazione del Ministero della Sanità. Sulle domande di autorizzazione esprime parere la Commissione di esperti prevista dall'articolo 6, comma 3, del decreto legislativo
30 dicembre 1992, n. 541, che a tal fine è integrata da un rappresentante del Dipartimento del Ministero della Sanità competente in materia di dispositivi medici e da uno del Ministero dell'Industria, del commercio e dell'artigianato.
Some of the contents of this website cannot be disclosed in the USA and its territories and possesions, for regulatory reasons. If you are a US resident, please click on the button here below and access ASA's distributor website for North America.